Roxithromycin Mekopharma Uses

sponsored

Roxithromycin Mekopharma indications

infoAn indication is a term used for the list of condition or symptom or illness for which the medicine is prescribed or used by the patient. For example, acetaminophen or paracetamol is used for fever by the patient, or the doctor prescribes it for a headache or body pains. Now fever, headache and body pains are the indications of paracetamol. A patient should be aware of the indications of medications used for common conditions because they can be taken over the counter in the pharmacy meaning without prescription by the Physician.
sponsored

Roxithromycin Mekopharma is indicated for the treatment of the following types of mild to

moderately severe infections caused by or likely to be caused by susceptible

micro-organisms: • upper respiratory tract infection - acute pharyngitis, tonsillitis and

sinusitis

• dental infections

• lower respiratory tract infection - acute bronchitis; acute exacerbations

of chronic bronchitis and community acquired pneumonia

• skin and skin structure infections

• non-gonococcal urethritis.

Uses of Roxithromycin Mekopharma in details

infoThere are specific as well as general uses of a drug or medicine. A medicine can be used to prevent a disease, treat a disease over a period or cure a disease. It can also be used to treat the particular symptom of the disease. The drug use depends on the form the patient takes it. It may be more useful in injection form or sometimes in tablet form. The drug can be used for a single troubling symptom or a life-threatening condition. While some medications can be stopped after few days, some drugs need to be continued for prolonged period to get the benefit from it.

Roxithromycin Mekopharma is used to treat ear, nose and throat infections, pneumonia (lung infection), skin infections and infections of the genitalia.

Roxithromycin Mekopharma description

Roxithromycin Mekopharma is a semi-synthetic macrolide antibiotic. It is very similar in composition, chemical structure and mechanism of action to erythromycin, azithromycin, or clarithromycin. Roxithromycin Mekopharma prevents bacteria from growing, by interfering with their protein synthesis. Roxithromycin Mekopharma binds to the subunit 50S of the bacterial ribosome, and thus inhibits the translocation of peptides. Roxithromycin Mekopharma has similar antimicrobial spectrum as erythromycin, but is more effective against certain gram-negative bacteria, particularly Legionella pneumophila. It can treat respiratory tract, urinary and soft tissue infections. It is in the United States, but is available in Australia.

Roxithromycin Mekopharma dosage

sponsored

Oral

Susceptible infections

Adult: 150 mg bid or 300 mg once daily for 5-10 days in susceptible infections.

Child: 6-40 kg: 5-8 mg/kg daily.

Renal impairment: Dosage adjustment may be required.

Hepatic impairment: Usual daily doses should be halved in hepatic impairment.

Roxithromycin Mekopharma interactions

Roxithromycin Mekopharma has a much lower affinity for cytochrome P450 than

erythromycin, and consequently has fewer interactions. Interactions may be

observed, however, with drugs that bind to alpha-1-acid glycoprotein, e.g.

disopyramide.

Roxithromycin Mekopharma does not appear to interact with oral contraceptives,

prednisolone, carbamazepine, ranitidine or antacids.

Theophylline. A study in normal subjects concurrently administered

Roxithromycin Mekopharma and theophylline has shown some increase in the plasma

concentration of the latter. While a change in dosage is usually not required,

patients with high levels of theophylline at commencement of treatment

should have levels monitored.

Ergot alkaloids. Reactions of ergotism with possible peripheral necrosis have

been reported after concomitant therapy of macrolides with vasoconstrictive ergot alkaloids, particularly ergotamine and dihydroergotamine. Because a

clinical interaction with Roxithromycin Mekopharma cannot be excluded, administration of

Roxithromycin Mekopharma to patients taking ergot alkaloids is contraindicated.

Disopyramide. An in vitro study has shown that Roxithromycin Mekopharma can displace

protein bound disopyramide; such an effect in vivo could result in increased

serum levels of disopyramide. Consequently, ECG and, if possible,

disopyramide serum levels should be monitored.

Terfenadine. Some macrolide antibiotics (e.g. erythromycin) may increase

serum levels of terfenadine. This can result in severe cardiovascular adverse

events, including QT prolongation, torsades de pointes and other ventricular

arrhythmias. Such a reaction has not been documented with Roxithromycin Mekopharma,

which has a much lower affinity for cytochrome P450 than erythromycin.

However, in the absence of a systematic interaction study, concomitant

administration of Roxithromycin Mekopharma and terfenadine is not recommended.

Astemizole, cisapride, pimozide. Other drugs, such as astemizole, cisapride

or pimozide, which are metabolised by the hepatic isozyme CYP3A4, have

been associated with QT interval prolongation and/or cardiac arrhythmias

(typically torsades de pointes) as a result of an increase in their serum level

subsequent to interaction with significant inhibitors of this isozyme, including

some macrolide antibacterials. Although Roxithromycin Mekopharma has no or limited ability

to complex CYP3A4 and hence to inhibit the metabolism of other drugs

processed by this isozyme, a potential for clinical interaction of Roxithromycin Mekopharma

with the above mentioned drugs cannot be either ascertained or ruled out in

confidence. Thus, concomitant administration of Roxithromycin Mekopharma and such drugs

is not recommended.

Warfarin. While no interaction was observed in volunteer studies,

Roxithromycin Mekopharma appears to interact with warfarin. Increases in prothrombin time

(international normalised ratio (INR)) have been reported in patients treated

concomitantly with Roxithromycin Mekopharma and warfarin or the related vitamin K

antagonist phenprocoumon, and severe bleeding episodes have occurred as

a consequence.

Digoxin and other cardiac glycosides. A study in healthy volunteers has

shown that Roxithromycin Mekopharma may increase the absorption of digoxin. This effect,

common to other macrolides, may very rarely result in cardiac glycoside

toxicity. This may be manifested by symptoms such as nausea, vomiting,

diarrhoea, headache or dizziness. Cardiac glycoside toxicity may also elicit

heart conduction and/or rhythm disorders. Consequently, in patients treated

with Roxithromycin Mekopharma and digoxin or another cardiac glycoside, ECG and, if

possible, the serum level of the cardiac glycoside should be monitored. This is

mandatory if symptoms suggesting cardiac glycoside overdosage have

occurred.

Midazolam. Roxithromycin Mekopharma, like other macrolides, may increase the area

under the midazolam concentration-time curve and the midazolam half-life.

Thus, the effects of midazolam may be enhanced and prolonged in patients treated with Roxithromycin Mekopharma. There is no conclusive evidence for an interaction

between Roxithromycin Mekopharma and triazolam.

Cyclosporin. A slight increase in plasma concentrations of cyclosporin A has

been observed. This does not generally necessitate altering the usual dosage.

Roxithromycin Mekopharma side effects

sponsored

Applies to benzoyl peroxide topical: topical bar, topical cream, topical foam, topical gel/jelly, topical liquid, topical lotion, topical pad, topical soap, topical solution

In addition to its needed effects, some unwanted effects may be caused by benzoyl peroxide topical (the active ingredient contained in Roxithromycin Mekopharma). In the event that any of these side effects do occur, they may require medical attention.

Major Side Effects

You should check with your doctor immediately if any of these side effects occur when taking benzoyl peroxide topical:

Less common or rare:

  • Painful irritation of skin, including burning, blistering, crusting, itching, severe redness, or swelling
  • skin rash
Incidence not known:
  • Difficult breathing
  • fainting
  • hives
  • itching
  • swelling of the eyes, face, lips, or tongue
  • tightness in the throat

If any of the following symptoms of overdose occur while taking benzoyl peroxide topical, get emergency help immediately:

Symptoms of overdose:

  • Burning, itching, scaling, redness, or swelling of skin (severe)

Minor Side Effects

Some of the side effects that can occur with benzoyl peroxide topical may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:

Less common:

  • Dryness or peeling of the skin (may occur after a few days)
  • feeling of warmth, mild stinging, and redness of the skin

Roxithromycin Mekopharma contraindications

sponsored

Hypersensitivity to Roxithromycin Mekopharma or macrolides including erythromycin. Severely impaired hepatic function. Vasoconstrictive ergot alkaloids.

Active ingredient matches for Roxithromycin Mekopharma:

Roxithromycin in Vietnam.


Unit description / dosage (Manufacturer)Price, USD
Roxithromycin Mekopharma 50 mg x 20 Packs x 1.5 g
Roxithromycin Mekopharma 150 mg x 1 Blister x 10 Tablet
Roxithromycin Mekopharma 150 mg x 10 Blister x 10 Tablet

List of Roxithromycin Mekopharma substitutes (brand and generic names):

Tablet, Film-Coated; Oral; Roxithromycin 300 mg
Roxithroxyl 150 mg x 10 Blister x 10 Tablet (Bangkok Lab & Cosmetic)
Roxithroxyl 150 mg x 100's (Bangkok Lab & Cosmetic)
Roxithroxyl 150 mg x 10 x 10's (Bangkok Lab & Cosmetic)
Roxithroxyl 300 mg x 10 x 10's (Bangkok Lab & Cosmetic)
Roxithroxyl film-coated tab 150 mg 10 x 10's (Bangkok Lab & Cosmetic)
Roxithroxyl film-coated tab 150 mg 100's (Bangkok Lab & Cosmetic)
Roxithroxyl film-coated tab 300 mg 10 x 10's (Bangkok Lab & Cosmetic)
ROXITID 150MG TABLET 1 strip / 10 tablets each (Ranbaxy Laboratories Ltd)$ 0.68
Roxitin 150 mg x 50 x 10's (T P Drug)
Roxitin 150 mg x 500's (T P Drug)
ROXITIS Capsule/ Tablet / 150mg / 10 units (Medley)$ 0.87
ROXITIS Dispersible Tablet / 50mg / 10 units (Medley)$ 0.39
Roxitis 50mg TAB / 10 (Medley)$ 0.39
Roxitis 150mg TAB / 10 (Medley)$ 0.87
Roxitis 50mg/5mL SUSP / 30ml (Medley)$ 0.47
50 mg x 10's (Medley)$ 0.39
150 mg x 10's (Medley)$ 0.87
50 mg x 5 mL x 30ml (Medley)$ 0.47
Roxitis 150 mg x 10 Blister x 10 Tablet (Medley)
ROXITIS tab 50 mg x 10's (Medley)$ 0.39
ROXITIS tab 150 mg x 10's (Medley)$ 0.87
ROXITIS oral susp 50 mg x 5 mL x 30ml (Medley)$ 0.47
Roxitis 50mg TAB / 10 (Medley)$ 0.39

References

  1. PubChem. "roxithromycin". https://pubchem.ncbi.nlm.nih.gov/compoun... (accessed September 18, 2017).

Reviews

The results of a survey conducted on ndrugs.com for Roxithromycin Mekopharma are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Roxithromycin Mekopharma. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 16 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2018 ndrugs.com All Rights Reserved